16 In the index

Telmisartan TELMI

An FDA-approved blood pressure medication that may also have some metabolic benefits related to insulin sensitivity and endurance. Its blood-pressure benefits are strongly proven; the metabolic effects are documented in smaller studies rather than dedicated large trials.

Also known as Micardis, Pritor, Kinzalmono, BIBR 277, Semintra, tolura, Telmisartan Teva

Effects Endurance Hormonal

Routes Oral

Legal status Prescription drug

WADA Not listed

3D Molecular Structure of C₃₃H₃₀N₄O₂

Drag to rotate · scroll to zoom

Chemistry

Formula: C33H30N4O2
Molar mass: 514.6
CAS: 144701-48-4
PubChem CID: 65999
IUPAC name: 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
InChIKey: RMMXLENWKUUMAY-UHFFFAOYSA-N

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 40-80 mg/day

Reported range 20-80 mg/day

Route Oral

Frequency Once daily

Duration Chronic/ongoing (as prescribed)

FDA-approved angiotensin receptor blocker (Micardis) for hypertension; also studied off-label for metabolic/insulin-sensitivity benefits at these same doses.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.